Clinical development of IMOJEV®—a recombinant Japanese encephalitis chimeric vaccine (JE-CV)

Concomitant or sequential administration of live attenuated Japanese encephalitis chimeric virus vaccine and yellow fever 17D vaccine

(2011) Peter E Nasveld et al.   Human vaccines & immunotherapeutics

Long term immunity to live attenuated Japanese encephalitis chimeric virus vaccine

(2011) Peter E. Nasveld et al.   Human vaccines & immunotherapeutics

IMOJEV®: a Yellow fever virus-based novel Japanese encephalitis vaccine

(2010) Mohan Babu Appaiahgari et al.   Expert Review of Vaccines

Safety and Immunogenicity of a Single Administration of Live-attenuated Japanese Encephalitis Vaccine in Previously Primed 2- to 5-year-olds and Naive 12- to 24-month-olds

(2010) Kulkanya Chokephaibulkit et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials

(2010) Joseph Torresi et al.   VACCINE

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

(2009) Bruno Guy et al.   VACCINE

Live Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis Virus

(2008) M. Lobigs et al.   JOURNAL OF VIROLOGY

A 5-year follow-up of antibody response in children vaccinated with single dose of live attenuated SA14-14-2 Japanese encephalitis vaccine: Immunogenicity and anamnestic responses

(2008) Young Mo Sohn et al.   VACCINE